Emicizumab prophylaxis overcomes factor VIII inhibitors in Hemophilia A

J Pediatr. 2017 Nov:190:287-290. doi: 10.1016/j.jpeds.2017.08.053.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Bispecific*
  • Antibodies, Monoclonal, Humanized
  • Factor VIII
  • Hemophilia A*
  • Humans

Substances

  • Antibodies, Bispecific
  • Antibodies, Monoclonal, Humanized
  • emicizumab
  • Factor VIII